bioRxivCell Biology
Carm1 regulates the speed of C/EBPa-induced transdifferentiation by a cofactor stealing mechanism
G. T. Garcia, E. Kowenz-Leutz, T. V. Tian, A. Klonizakis, J. Lerner, L. De Andres-Aguayo, C. Berenguer, M. P. Carmona, M. V. Casadesus, R. Bulteau, M. Francesconi, S. Peiro, K. S. Zaret, A. Leutz, T. Graf
Abstract
Cell fate decisions are driven by lineage-restricted transcription factors but how they are regulated is incompletely understood. The C/EBP-induced B cell to macrophage transdifferentiation (BMT) is a powerful system to address this question. Here we describe that C/EBP with a single arginine mutation (C/EBPR35A) induces a dramatically accelerated BMT in mouse and human cells. Changes in the expression of lineage-restricted genes occur as early as within 1 hour compared to 18 hours with the wild type. Mechanistically C/EBPR35A exhibits an increased affinity for PU.1, a bi-lineage transcription factor required for C/EBP-induced BMT. The complex induces more rapid chromatin accessibility changes and an enhanced relocation (stealing) of PU.1 from B cell to myeloid gene regulatory elements. Arginine 35 is methylated by Carm1 and inhibition of the enzyme accelerates BMT, similar to the mutant. Our data suggest that the relative proportions of methylated and unmethylated C/EBP in a bipotent progenitor can determine the velocity of cell fate choice and lineage directionality.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: development & morphogenesis
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Arginine methylation of the p30 C/EBPα oncoprotein regulates progenitor proliferation and myeloid differentiation
L. T. Nguyen, K. Zimmermann, … A. Leutz·bioRxiv·Mar 28, 2024
- A C/ebpα isoform-specific differentiation program in primary myelocytes
M.-P. Garcia-Cuellar, S. Akan, R. K. Slany·bioRxiv·May 16, 2023
- Alu-mediated weak CEBPA binding and slow B cell transdifferentiation in human
Ramil Nurtdinov, María Sanz, … Roderic Guigó·bioRxiv·Oct 28, 2021
- MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia
Dorien Pastoors, Marije Havermans, … Ruud Delwel·BloodPeer-reviewed·Oct 8, 2025
- Transcriptional activation of Il36A by C/EBPβ via a half-CRE*C/EBP element in murine macrophages is independent of its CpG methylation level
Andreas G. Nerlich, Nina Janze, Ralph Goethe·Genes and ImmunityPeer-reviewed·Oct 25, 2021
- The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
Andrea Repele, Shawn Krueger, … Manu·PLoS ONEPeer-reviewed·Jun 10, 2019